Post-hoc analysis of data from a trial (NCT02975349) of evobrutinib (EMD Serono, Rockland, MA) for relapsing forms of multiple sclerosis (MS) showed r
According to long-term study results, earlier treatment with Ocrevus (ocrelizumab; Genentech, South San Francisco, CA) resulted in greater reductions
New study results showed that individuals with essential tremor had or developed dementia at a rate 3 times higher than the general population and had
Physicians and medical institutions need to take steps to recognize and combat imposter phenomenon, also known as imposter syndrome.
Ultrasound guidance did not significantly affect the outcomes of lumbar puncture (LP) performed by a single experienced practitioner in the outpatient
Despite its heterogeneous clinical presentation, vasculitic neuropathy requires rapid identification and treatment to prevent diagnostic delay or lack of diagnosis.
Abbott (Chicago, IL) announced that the FDA has granted 510(k) clearance to the i-STAT TBI cartridge. The portable i-STAT TBI cartridge system enables
I am thrilled to share these comprehensive, clinically focused reviews on topics describing neuromuscular mechanisms as targets of the immune system.
Viz.ai (San Francisco, CA) announced a strategic collaboration with Medtronic (Minneapolis, MN) to improve the coordination of cryptogenic stroke pati
Comprehensive neurodiagnostic evaluation is significantly underused by clinicians managing patients with drug-resistant epilepsy (DRE), as shown
According to study results published in JAMA, a high proportion of people with Parkinson disease (PD), multiple system atrophy (MSA), dementia with Le
